Found 4 matching trials
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
PHASE2Targeted drug therapies have greatly improved outcomes for patients with re...
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
PHASE1This study will evaluate the safety, antitumor activity and preliminary pha...
BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma
PHASE1The Primary Objective is to evaluate the safety and tolerability of the DTR...
Location
Peking University Cancer Hospital
Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas
PHASE1The Primary Objective is to evaluate the safety and tolerability of multipl...
Location
Peking University Cancer Hospital